Theratechnologies (TSE:TH) and Fennec Pharmaceuticals (TSE:FRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership and dividends.
Valuation and Earnings
This table compares Theratechnologies and Fennec Pharmaceuticals' revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|
| Theratechnologies | C$65.76 million | 6.29 | C$-35,948,380.00 | C($0.38) | -11.50 |
| Fennec Pharmaceuticals | C$170,000.00 | 1,153.31 | C$-24,858,868.00 | C($0.96) | -7.89 |
Fennec Pharmaceuticals has lower revenue, but higher earnings than Theratechnologies. Theratechnologies is trading at a lower price-to-earnings ratio than Fennec Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Theratechnologies and Fennec Pharmaceuticals' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
|---|
| Theratechnologies | N/A | N/A | N/A |
| Fennec Pharmaceuticals | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Theratechnologies and Fennec Pharmaceuticals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|
| Theratechnologies | 0 | 2 | 0 | 0 | 2.00 |
| Fennec Pharmaceuticals | 0 | 0 | 2 | 0 | 3.00 |
Theratechnologies presently has a consensus price target of C$3.75, suggesting a potential downside of 14.38%. Given Theratechnologies' higher probable upside, equities analysts plainly believe Theratechnologies is more favorable than Fennec Pharmaceuticals.
Summary
Fennec Pharmaceuticals beats Theratechnologies on 5 of the 8 factors compared between the two stocks.
